News Focus
News Focus
Followers 461
Posts 37019
Boards Moderated 0
Alias Born 01/11/2004

Re: ChannelTrader post# 6144

Saturday, 08/23/2008 12:20:36 PM

Saturday, August 23, 2008 12:20:36 PM

Post# of 41474
Is this the business we're going into???

Pluristem Life Systems, Inc. is a life sciences driven company that is developing and commercializing stem cell expansion technology products for the treatment of severe blood disorders. The Company is discovering and developing cell-based therapeutics that utilizes adult stem cells expanded in a proprietary bioreactor mimicking different naturally occurring physiological environments. Pluristem expects its first products to be cell grafts that will provide an efficient and superior alternative to the standard procedure of bone marrow transplantation. Its first adult stem cell product is intended to target a critical global shortfall of matched tissue for bone marrow transplantation since bone marrow transplantation is often the only cure for patients suffering from leukemia, lymphoma, myeloma and many other hematological diseases. The Company has made a strategic decision to work only with adult stem cells since the practical use of embryonic stem cells is severely restricted by various religious, ethical and legal considerations.

http://www.pluristem.com

PLURISTEM THERAPEUTC(NasdaqCM: PSTI) http://finance.yahoo.com/q?s=PSTI





Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today